carnitine has been researched along with MS (Multiple Sclerosis) in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The serum concentrations of total, free and acylcarnitine were compared in 25 patients with multiple sclerosis (MS) and among age- and sex-matched normal controls by the new enzymatic cycling method in order to clarify whether the fatigue in MS might be due to possible carnitine-related fatty acid metabolic abnormalities in the mitochondria of skeletal muscles." | 7.69 | Serum carnitine and disabling fatigue in multiple sclerosis. ( Fukazawa, T; Hamada, T; Kikuchi, S; Sasaki, H; Tashiro, K, 1996) |
| "Although frank symptomatic biotin deficiency is rare, some evidence suggests that marginal biotin deficiency occurs spontaneously in a substantial proportion of women during normal human pregnancy and might confer an increased risk of birth defects." | 4.95 | Biotin: From Nutrition to Therapeutics. ( Mock, DM, 2017) |
| " We included studies investigating pemoline and modafinil in participants with multiple sclerosis (MS)-associated fatigue and methylphenidate in patients suffering from advanced cancer and fatigue in meta-analysis." | 4.91 | Pharmacological treatments for fatigue associated with palliative care. ( Cuhls, H; Minton, O; Mücke, M; Peuckmann-Post, V; Radbruch, L; Stone, P, 2015) |
| "The serum concentrations of total, free and acylcarnitine were compared in 25 patients with multiple sclerosis (MS) and among age- and sex-matched normal controls by the new enzymatic cycling method in order to clarify whether the fatigue in MS might be due to possible carnitine-related fatty acid metabolic abnormalities in the mitochondria of skeletal muscles." | 3.69 | Serum carnitine and disabling fatigue in multiple sclerosis. ( Fukazawa, T; Hamada, T; Kikuchi, S; Sasaki, H; Tashiro, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Teixeira, CF | 1 |
| Azzolin, VF | 1 |
| Rodrigues Dos Passos, G | 1 |
| Turra, BO | 1 |
| Alves, AO | 1 |
| Bressanim, ACM | 1 |
| Canton, LEL | 1 |
| Vieira Dos Santos, AC | 1 |
| Mastella, MH | 1 |
| Barbisan, F | 1 |
| Ribeiro, EE | 1 |
| Duarte, T | 1 |
| Duarte, MMMF | 1 |
| Bonotto, NCA | 1 |
| Sato, DK | 1 |
| da Cruz, IBM | 1 |
| Mock, DM | 1 |
| Rossi, C | 3 |
| Cicalini, I | 2 |
| Zucchelli, M | 2 |
| di Ioia, M | 3 |
| Onofrj, M | 2 |
| Federici, L | 2 |
| Del Boccio, P | 3 |
| Pieragostino, D | 3 |
| Agnifili, L | 1 |
| Mastropasqua, L | 1 |
| De Luca, G | 1 |
| D'Alessandro, M | 1 |
| Urbani, A | 1 |
| Di Ilio, C | 1 |
| Lugaresi, A | 1 |
| Sacchetta, P | 1 |
| Akaishi, T | 1 |
| Nakashima, I | 1 |
| Misu, T | 1 |
| Fujihara, K | 1 |
| Aoki, M | 1 |
| Mücke, M | 1 |
| Cuhls, H | 1 |
| Peuckmann-Post, V | 1 |
| Minton, O | 1 |
| Stone, P | 1 |
| Radbruch, L | 1 |
| Laffon-Pioger, M | 1 |
| Rocher, F | 1 |
| Caruba, C | 1 |
| Cohen, M | 1 |
| Thomas, P | 1 |
| Lebrun, C | 1 |
| Fukazawa, T | 1 |
| Sasaki, H | 1 |
| Kikuchi, S | 1 |
| Hamada, T | 1 |
| Tashiro, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proteomic and Lipidomic Profiling of Coronary Thrombus in Acute Myocardial Infarction[NCT03731884] | 50 participants (Anticipated) | Observational | 2017-01-01 | Recruiting | |||
| Feasibility Study of Adjunctive Bright Light Therapy (BLT) for Amelioration of Fatigue in Chinese Cancer Patients Admitted to a Palliative Care Unit[NCT04525924] | 42 participants (Anticipated) | Interventional | 2020-08-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for carnitine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Biotin: From Nutrition to Therapeutics.
Topics: Animals; Biotin; Biotinylation; Carnitine; Female; Gene Expression; Hormones; Humans; Multiple Scler | 2017 |
Pharmacological treatments for fatigue associated with palliative care.
Topics: Adult; Amantadine; Benzhydryl Compounds; Carnitine; Central Nervous System Stimulants; Chronic Disea | 2015 |
1 trial available for carnitine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Carnitine serum levels and levocarnitine administration in multiple sclerosis patients treated with natalizumab.
Topics: Antibodies, Monoclonal, Humanized; Carnitine; Cohort Studies; Fatigue Syndrome, Chronic; Female; Hum | 2011 |
6 other studies available for carnitine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
A coffee enriched with guarana, selenium, and l-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: A pilot study.
Topics: Carnitine; Coffee; Cytokines; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; N | 2023 |
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy.
Topics: Adult; Amino Acids; Biomarkers; Carnitine; Case-Control Studies; Female; Gonadal Steroid Hormones; H | 2018 |
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid.
Topics: Adult; Amino Acids; Biomarkers; Carnitine; Central Nervous System; Chromatography, Liquid; Female; H | 2019 |
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
Topics: Biomarkers; Carnitine; Glutamic Acid; Humans; Lipids; Metabolome; Metabolomics; Multiple Sclerosis | 2015 |
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Topics: Adult; Aged; Carnitine; Chronic Disease; Comorbidity; Depression; Fatigue; Female; Gait Disorders, N | 2015 |
Serum carnitine and disabling fatigue in multiple sclerosis.
Topics: Adult; Carnitine; Fatigue; Fatigue Syndrome, Chronic; Female; Humans; Male; Mitochondria, Muscle; Mu | 1996 |